The Asthma Foundation in Sierra Leone

The Asthma Foundation in Sierra Leone is dedicated to raising awareness about asthma and other respiratory conditions.

[The Asthma Foundation in Sierra Leone @AsthmaFound]

450,000+ people die from asthma annually. Most of these deaths are preventable. This #WorldAsthmaDay, we’re calling on stakeholders to ensure access to ICS in all countries and biologics for severe cases. Learn more: https://t.co/zXrKwZXVKq
#AsthmaCareforEveryone

[The Asthma Foundation in Sierra Leone @AsthmaFound]

🌍 *World Allergy Awareness Week*

The Asthma Foundation in Sierra Leone is proud to join the global community in raising awareness during World Allergy Awareness Week. This important observance highlights the impact of allergies on individuals and families.

[Global Allergy & Airways Patient Platform @gaapporg]

GAAPP joins GA2LEN and UNEV for Urticaria Day (#UDAY2026) – a global opportunity to raise awareness of this often-misunderstood condition and to empower patients, caregivers, and healthcare professionals to Take Back Control. 🔗 https://t.co/y4ADIa6H91

[Global Allergy & Airways Patient Platform @gaapporg]

Dupilumab pooled analysis (N=1,874) shows 31% fewer COPD exacerbations, sustained lung function improvement & better QoL in type 2 inflammation. 1st biologic with potential consistent efficacy in COPD. Co-authored by GAAPP's President & CEO Tonya Winders.
https://t.co/AukNawYYT3

[Global Allergy & Airways Patient Platform @gaapporg]

This #WorldAllergyWeek, we join forces with WAO and EUFOREA to call for improved access to allergy care worldwide. Adequate treatment reduces the financial burden on health systems.
👉 https://t.co/Y4L8yzZORc
👉 https://t.co/Zr3GwJHbCA

[Global Allergy & Airways Patient Platform @gaapporg]

Did you hear the click? ⛽️
Our partners at @CleanAirPartner say that's your sign to stop filling your #gas tank. 🙅 Topping off not only releases harmful chemicals into the #air, 💨 it also reduces fuel #efficiency 📉 and can even do costly damage to your car. 🧰

#SupportedbyGAAPP

[Global Allergy & Airways Patient Platform @gaapporg]

GAAPP will be attending the 13th IPCRG World Conference from 11–14 June 2026. Visit our team at the GAAPP booth to learn more about our latest advocacy tools, educational resources, and how we are working to improve lung health for patients everywhere.
👉 https://t.co/hVvdG5sc9K

#IPCRG2026

[Global Allergy & Airways Patient Platform @gaapporg]

Join us for an engaging GAAPP Academy session with our President & CEO Tonya Winders focused on refining your messaging and develop a clear, confident “pitch” you can use with policymakers, partners, funders, media, and your community.
📅 30 April ⏰ 15:00 CET
🔗 Register: https://t.co/NiWSGLXFuJ

[Global Allergy & Airways Patient Platform @gaapporg]

Nasal obstruction and lost sense of smell and taste are the most severe and prevalent symptoms reported by people with chronic rhinosinusitis with nasal polyps (CRSwNP). Learn more: https://t.co/lguV7kCK4a

#GlobalCRSwNPAwarenessDay

[Global Allergy & Airways Patient Platform @gaapporg]

Over 60% of people with chronic rhinosinusitis with nasal polyps (CRSwNP) experience reduced sleep quality. Learn more: https://t.co/lguV7kCK4a
Adults in the US or Canada with CRS with nasal polyps in both nostrils: Contact [email protected] for participation in a research panel

[Global Allergy & Airways Patient Platform @gaapporg]

Join us for a GAAPP Academy session with our President & CEO Tonya Winders focused on refining your messaging and developing a clear, confident pitch you can use with policymakers, partners, funders, media, and your community. 30 April at 15:00 CET.
🔗 https://t.co/wmd9xHPU0l

[Global Allergy & Airways Patient Platform @gaapporg]

For many people with eosinophilic esophagitis (EoE), the path to a meal is often tangled with fear and uncertainty. Today, GAAPP and the #EoEDay Alliance launch the #FoodShouldNotHurt campaign. We are untangling the complexity of EoE care. Stay tuned.
👉 https://t.co/u2kHl4SQ5D

[Global Allergy & Airways Patient Platform @gaapporg]

Stay updated on our progress and the upcoming advocacy news by subscribing to our newsletter: https://t.co/CuOXBzm0HT
#IRC2026 #CSEA3

[Global Allergy & Airways Patient Platform @gaapporg]

A person with eosinophilic esophagitis (EoE) often feels like their esophagus is tied in knots. To support clinical excellence, the EoE Day Alliance developed a comprehensive management algorithm to standardize care. Access the EoE Care Pathway: https://t.co/oCAroVtz3f

[Global Allergy & Airways Patient Platform @gaapporg]

GAAPP will be at the ATS International Conference 2026. Across May 17 & 19, we’ll be sharing insights on people with CRSwNP, patient experience with new inhaled treatments, wellbeing with COPD and new therapies, and community perspective on vaccines. Come say hello! #ATS2026

[Global Allergy & Airways Patient Platform @gaapporg]

Tomorrow, join @GAAPPorg and @gsk for a #WorldAsthmaDay deep dive into clinical remission. We’re moving the conversation from "management" to "remission" with experts Dr. Alan Kaplan (🇨🇦) & Christian Ukegbu (🇳🇬🇬🇧). 5 May 2026 15:30 CET. Register: https://t.co/gizuMyPnHR

[Global Allergy & Airways Patient Platform @gaapporg]

450,000+ people die from asthma annually. Most of these deaths are preventable. This #WorldAsthmaDay, we’re calling on stakeholders to ensure access to ICS in all countries and biologics for severe cases. Learn more: https://t.co/yz4kT09Nc7
#AsthmaCareforEveryone

[Global Allergy & Airways Patient Platform @gaapporg]

Join GAAPP President Tonya Winders & experts for a new @Medscape CME workshop on overcoming adherence barriers in COPD & asthma. Free for global HCPs: https://t.co/qjqhDjKMZX
#CME #RespiratoryHealth #HCP

[Global Allergy & Airways Patient Platform @gaapporg]

New Ph3 data for lebrikizumab-lbkz shows 63% of pediatric patients (6mo+) achieved EASI-75. 🔗 https://t.co/kB924usDmI

[Global Allergy & Airways Patient Platform @gaapporg]

Call for Abstracts for Early Career Researchers: share your work at ICAN 2026 (5 September, Barcelona). Join a collaborative community advancing respiratory research — from immune mechanisms and treatment response to AI, imaging, and novel therapies. Connect with peers and global experts across academia, industry, NIH, ERS, and more. Only 50 abstracts will be selected.
✈️ Selected abstracts will receive travel support + accommodation
📅 Deadline: 15 April, 2026
🔗 https://t.co/3Rg9qNxw30